Which patient with thyroid cancer deserves systemic therapy and when?
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference8 articles.
1. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy;Durante;JCEM,2006
2. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer;Schlumberger;NEJM,2015
3. Sorafenib in locally advanced or metastatic, radioactive iodine- refractory, differentiated thyroid cancer: a randomized, double- blind, phase 3.;Brose;Lancet,2014
4. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer;Haugen;Thyroid,2016
5. Second primary malignancies in thyroid cancer patients;Rubino;Br J Cancer,2003
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Summary and update on the management of differentiated thyroid cancer in 2023;Annales d'Endocrinologie;2024-04
2. Management of Advanced Thyroid Cancer: Overview, Advances, and Opportunities;American Society of Clinical Oncology Educational Book;2023-05
3. Definition of Radioactive Iodine Refractory Thyroid Cancer and Redifferentiation Strategies;Integrated Diagnostics and Theranostics of Thyroid Diseases;2023
4. Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan Is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer;Diagnostics;2022-05-18
5. Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022];Endokrynologia Polska;2022-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3